We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Endoscopic Device for Treating GERD

By HospiMedica staff writers
Posted on 14 Jul 2003
A new device designed for the transoral treatment of gastroesophageal reflux disease (GERD) eliminates the need for surgical incisions. More...
The device has been cleared by the US Food and Drug Administration (FDA).

Called the Plicator, the device secures and fixates tissue at the gastroesophageal junction to restore the natural anti-reflux barrier, using direct endoscopic visualization throughout the procedure. The Plicator is intended to provide a lasting solution to GERD. Current treatment options range from prescription medications to laparoscopic surgery. Although medications can relieve heartburn, they often require a life-long regimen and do not treat the underlying mechanical defect causing the problem.

"Typically, procedures took 20 minutes or less, with patients going home within a few hours of treatment,” said Dr. Douglas Pleskow, of Beth Israel Deaconess Medical Center (Boston, MA, USA), principal investigator for a study evaluating the safety and efficacy of the Plicator. "Thus far, we've been encouraged by our results, with most patients experiencing symptom relief while discontinuing their daily prescription medications for heartburn.”

The Plicator was developed by NDO Surgical (Mansfield, MA, USA), a medical technology company dedicated to the development of endoscopic solutions for gastrointestinal disease.




Related Links:
NDO Surgical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.